Search Results
Search for other papers by LESLIE MYATT in
Google Scholar
PubMed
Search for other papers by GAUTAM CHAUDHURI in
Google Scholar
PubMed
Search for other papers by M. G. ELDER in
Google Scholar
PubMed
Search for other papers by LOUIS LIM in
Google Scholar
PubMed
The presence of an intra-uterine device in the rat results in a lower nuclear concentration of the oestrogen receptor in the treated horn at pro-oestrus when it is compared with the contralateral control horn. This effect was also seen after the administration of hyperphysiological doses of oestradiol and when the horn was exposed in vitro to high concentrations of oestradiol. The cyclic changes during the oestrous cycle in the activity of the oestrogen-induced enzyme peroxidase were similar in the treated and control horns. These observations have discounted the possibility that the relatively lower nuclear receptor content in the treated horn at pro-oestrus was due to a decreased exposure to oestrogen. A significantly lower nuclear content was also observed in the treated horn on days 4 and 5 of pregnancy. This was not associated with a deficiency in cytosol receptor content which increased concurrently with that of the control horn in the 6 days of pregnancy that were studied. The proportional content of the putative cytosol factor implicated in receptor translocation was similar in both horns, increasing on days 4 and 6 in concert with reported changes in 'induced protein' synthesis. There appeared to be reduced levels of nuclear receptor at a time when blastocyst implantation normally occurs.
Search for other papers by LESLIE MYATT in
Google Scholar
PubMed
Search for other papers by M. G. ELDER in
Google Scholar
PubMed
Search for other papers by LOUIS LIM in
Google Scholar
PubMed
The binding characteristics, content and intracellular distribution of cytosolic and nuclear progesterone receptors have been investigated, using [3H]progesterone as ligand, in the rat uterus bearing a unilateral intra-uterine device (IUD) during the oestrous cycle and from days 3 to 6 of pregnancy. The dissociation constants of nuclear and cytosolic progesterone–receptor complexes for IUD-containing and control uterine horns were similar. Cytosolic receptor concentrations in the IUD-containing uterus were always lower but changed in a manner similar to the control during the periods studied. Nuclear receptor concentrations in the control horn reflected changes in hormone levels during the oestrous cycle although concentrations measured were greater than previously reported. However, in IUD-containing uteri the pattern was completely reversed with minimal levels at pro-oestrus. Nuclear receptor concentrations were little different in both horns during early pregnancy. Total progesterone receptor synthesis determined between metoestrus and pro-oestrus in IUD-containing horns was significantly less than that of control horns. This correlated with the attenuated rise of nuclear oestrogen receptor levels previously observed between these times in IUD-containing uterine horns.
Search for other papers by E. Y. ADASHI in
Google Scholar
PubMed
Search for other papers by A. J. W. HSUEH in
Google Scholar
PubMed
Search for other papers by S. S. C. YEN in
Google Scholar
PubMed
Alterations in the concentrations of oestrogen receptors in the uterus, pituitary gland and hypothalamus during the 2 weeks following a single administration of clomiphene citrate (Clomid) to immature, bilaterally ovariectomized rats were investigated. Examination of the uterine wet weight at 1, 7 and 14 days following a single injection of Clomid (100 μg, 250 μg or 10 mg) indicated significant time- and dose-related increments from a control value of 45 ± 2 (s.e.m.) mg to a maximum of 123 ± 3 mg (250 μg dose at 14 days). In contrast, a single injection of oestradiol led to a transient increase in the uterine weight on day 1 to 94 ± 6 mg, but was without effect by days 7 and 14. Analysis of the uterine DNA content 7 and 14 days after treatment with Clomid revealed significant increments from control values of 390 ± 10 μg to a high level of 558 ± 8 μg (10 mg dose at 7 days). There was a transient retention of nuclear oestrogen receptors and rapid replenishment of cytoplasmic oestrogen receptors in less than 24 h in the uteri of animals treated with oestradiol (25 μg), but determinations of receptor content in Clomid-treated animals revealed prolonged retention of nuclear receptors and delayed replenishment of cytoplasmic receptors. The duration and extent of retention of nuclear receptors and depletion of cytoplasmic receptors after treatment with Clomid were found to be dose-dependent. Fourteen days after Clomid treatment, levels of oestrogen receptors in nuclei from the uterus were still raised in all treatment groups, whereas replenishment of cytoplasmic receptors was complete in animals treated with the lower doses (100 and 250 μg) of Clomid.
A single injection of Clomid (250 μg) induced similar prolonged retention of nuclear receptors and delayed depletion of cytoplasmic receptors in pituitary tissue. In contrast, changes in the content of oestrogen receptors in the hypothalamus following Clomid treatment were minimal. The limited effect of Clomid on hypothalamic tissue may mean that the pituitary gland is a more important target for this compound than is the hypothalamus. The findings have confirmed earlier reports on the long-term uterotrophic effect of Clomid and have suggested that under these long-term, in-vivo conditions, Clomid acts in the uterus and pituitary gland as a long-acting oestrogen characterized by prolonged retention of oestrogen receptors in the nucleus and delayed, but otherwise effective, replenishment of the oestrogen receptors in the cytoplasm.
Search for other papers by M. G. Parker in
Google Scholar
PubMed
Hormone receptors which function in the cell nucleus to regulate the expression of specific genes appear to be members of a discrete family of proteins. The best characterized of these are the steroid receptors which, not too surprisingly, share similar structural and functional properties with one another (King, 1987) but it is now emerging from molecular cloning studies that the receptors for thyroid hormone and retinoic acid and a number of novel receptors are also members of this same family of proteins (Table 1). The justification for assigning all these nuclear-acting receptors to a single family of proteins is the subject of this commentary.
table 1. Members of the nuclear receptor family. Receptors which have been cloned are listed together with the chromosomal location of the human genes if known
Androgens (X) Thyroid hormone α (17)
Glucocorticoids (5) Thyroid hormone β (3)
Mineralocorticoids (4)
Oestrogens (6) Retinoic acid α (17)
Search for other papers by W. I. P. MAINWARING in
Google Scholar
PubMed
SUMMARY
A thermolabile protein with the properties of a steroid 'receptor' was identified in the cytoplasmic or 105,000 g supernatant fraction of the rat prostate. The receptor has a particular binding specificity towards 5αdihydrotestosterone. Testosterone is bound to a lesser extent but other steroids, including certain androgenic hormones, are not bound. The sedimentation coefficient of 8·0 s and the frictional ratio of 1·96, equivalent to a molecular weight of 2·74 × 105, clearly distinguish the soluble androgen-receptor from the androgen-binding globulin in serum and the androgen-receptor in the prostatic nucleus. Like the nuclear receptor, however, the soluble receptor is probably an acidic protein. Both cysteine and tryptophan residues appear necessary for maintaining the functional configuration of the receptor.
Search for other papers by R. I. NICHOLSON in
Google Scholar
PubMed
Search for other papers by P. DAVIES in
Google Scholar
PubMed
Search for other papers by K. GRIFFITHS in
Google Scholar
PubMed
SUMMARY
Studies on the mode of action of tamoxifen have shown that this compound ultimately causes regression of mammary tumours induced in female rats by 7,12-dimethylbenz(a)-anthracene, but induces preliminary effects similar to those produced by oestradiol-17β. Following a single intravenous injection of either substance, a sequence of events was observed which included depletion of cytoplasmic receptor, a concomitant increase in nuclear receptor and a subsequent replenishment of cytoplasmic receptor. Tamoxifen and oestradiol-17β induced a transient increase in RNA polymerase B activity, followed by increases in RNA polymerase A and, again, RNA polymerase B activity. Tamoxifen, unlike oestradiol-17β, could not maintain replenishment of cytoplasmic receptor, the increase in RNA polymerase A activity or the secondary rise in RNA polymerase B activity. The basic anti-oestrogenic properties of tamoxifen may be implicit in its inability to maintain oestrogenic stimulation, and may be linked to its retention time within the nuclei.
Search for other papers by M. Hubank in
Google Scholar
PubMed
Search for other papers by A. K. Sinha in
Google Scholar
PubMed
Search for other papers by D. Gullo in
Google Scholar
PubMed
Search for other papers by R. P. Ekins in
Google Scholar
PubMed
ABSTRACT
Tri-iodothyronine (T3) binding studies were performed on neuronal and glial nuclei prepared from developing rats brain by discontinuous sucrose gradient centrifugation. Maximum binding capacities (MBC) and dissociation constants (K d) were obtained from Eadie-Hofstee plots of transformed data. An ontogenic study on nuclei prepared from whole brain revealed that on day 5 after birth, glial nuclear MBC was 1774±201 (s.e.m.) fmol/mg DNA compared with 974±117 fmol/mg DNA for the neurones (P<0·01). Although diminishing to 667±112 fmol/mg DNA by day 21, alterations in neuronal MBC over the neonatal period were not statistically significant, whereas glial MBC diminished steadily to 557±133 fmol/mg DNA in glial nuclei (P<0·05). Over the same period, a significant reduction in K d was noted only in the glia, from 3·17±0·40 to 1·83±0·34 nmol/l (P<0·03). Ligand specificity of the receptor in both nuclear types on day 21 was tri-iodoacetic acid > T3 > thyroxine > 3,3′,5′-T3, but this was less clearly demonstrated at day 5.
Regional studies on days 15 and 21 demonstrated that for both neuronal and glial nuclei, receptors are concentrated in the cerebral cortex and diminish in a cranio-caudal direction. Cerebral glial MBC on day 21 was 2215±147 fmol/mg DNA, at this stage still exceeding the cerebral neuronal capacity of 1111±207fmol/mg DNA. The results indicate that neonatal glia may respond directly to thyroid hormones via nuclear receptor binding, and that receptors are predominantly located in the cortex. Decreases in average MBC in the late neonate may be due to increases in the numbers of cells containing fewer nuclear receptors.
Journal of Endocrinology (1990) 126, 409–415
Search for other papers by S. P. Bowman in
Google Scholar
PubMed
Search for other papers by A. Leake in
Google Scholar
PubMed
Search for other papers by I. D. Morris in
Google Scholar
PubMed
High-affinity oestrogen receptors were measured in the cytosol and nuclei prepared from the hypothalamus, pituitary gland and uterus of the ovariectomized rat up to 16 days after a single dose of tamoxifen or 4-hydroxytamoxifen. Tamoxifen produced a dose-related fall in the concentration of cytosol receptors in the hypothalamus, pituitary gland and uterus. Minimum values were observed after 24 h; cytosol receptor concentrations were restored slowly and only reached expected control values between 4 and 8 days and 2 and 4 days for 7·0 mg/kg and 0·7 mg/kg doses of tamoxifen respectively. The nuclear receptor changes were inversely related to the cytosol receptor changes, except that hypothalamic nuclear receptor concentrations after 0·7 mg tamoxifen/kg were not changed. 4-Hydroxytamoxifen (0·14 mg/kg) depleted cytosol and raised nuclear oestrogen receptors in the pituitary gland and uterus. Receptor concentrations had returned to the expected control values by day 4. Oestrogen receptor concentrations in the hypothalamus were unchanged. The apparent resistance of the receptor system in the hypothalamus to translocation by tamoxifen and 4-hydroxytamoxifen was probably due to the blood–brain barrier since the apparent affinity of tamoxifen for the cytosol receptor was similar for all three tissues (dissociation constant 4 nmol/l).
Serum concentrations of tamoxifen and 4-hydroxytamoxifen measured after a single dose of 7·0 mg tamoxifen/kg were maximal after 24 h and undetectable by 4 days, at which time nuclear and cytosol receptor levels were still changed. Concentrations of 4-hydroxy-tamoxifen were approximately one-third those of tamoxifen. The results suggest that the receptor changes after tamoxifen are not simply related to the serum concentration of tamoxifen and its metabolites and that the retention of ligand within the target tissue may be an important determinant.
Search for other papers by M L Jaffrain-Rea in
Google Scholar
PubMed
Search for other papers by E Petrangeli in
Google Scholar
PubMed
Search for other papers by F Ortolani in
Google Scholar
PubMed
Search for other papers by B Fraioli in
Google Scholar
PubMed
Search for other papers by A Lise in
Google Scholar
PubMed
Search for other papers by V Esposito in
Google Scholar
PubMed
Search for other papers by L G Spagnoli in
Google Scholar
PubMed
Search for other papers by G Tamburrano in
Google Scholar
PubMed
Search for other papers by L Frati in
Google Scholar
PubMed
Search for other papers by A Gulino in
Google Scholar
PubMed
Abstract
Cellular receptors for sex steroids (SSRs) were studied in an unselected series of 55 human pituitary tumors. Cytosolic receptors for estrogen (ERcs) and progesterone (PgRcs) were determined in all cases and cytosolic androgen receptors (ARcs) in 47 cases. Nuclear receptors (ERns, PgRns, ARns) were also studied in 33 cases. ERs and PgRs were determined by an ELISA and ARs by [3H]methyltrienolone binding. Where both cytosolic and nuclear receptors were studied (n=33), ERs, PgRs and ARs were found in at least one subcellular fraction in 66·7, 60·6 and 81·8% of cases respectively, ERs and ARs being mainly recovered from the cytosol and PgRs from the nucleus. No linear correlation was found between preoperative plasma steroid hormones and their specific cellular receptors. Nonetheless, the differential expression of SSRs according to sex and gonadal status at the time of surgery strongly supports their regulation by the steroid environment in vivo: PgRcs were more frequent in tumors found in women (41·4 vs 15·4%, P<0·05), whereas a high expression of ERcs and ARcs (>15 fmol/mg protein) was more common in tumors found in men (34·5 vs 10·3%, P<0·05 and 54·5 vs 24·0% respectively). PgRs were positively correlated with ERns, indicating the possibility of estrogen priming of their expression, and negatively correlated with ARs in nuclear fractions. SSRs appeared to be widely distributed among pituitary tumors, although, compared with other hormone-secreting groups, prolactinomas displayed a higher ERc expression (34·8 ± 11·3 vs 4·8 ± 5·1 fmol/mg protein, P=0·007) and gonadotroph cell adenomas lower ARc values (1·3 ± 0·8 vs 38·2 ± 10·6 fmol/mg protein, P=0·048). Microadenomas were characterized by a higher PgR expression than macroadenomas, whereas hemorrhagic (macro)adenomas were characterized by a high ER expression (>90%). The present results indicate that most pituitary tumors are targets for sex steroids, SSR expression being partially triggered by the steroid environment itself. Possible physiopathological and therapeutic implications of these findings are discussed.
Journal of Endocrinology (1996) 151, 175–184
Search for other papers by J. Kvetny in
Google Scholar
PubMed
Search for other papers by L. Matzen in
Google Scholar
PubMed
ABSTRACT
Nuclear tri-iodothyronine (T3) maximal binding capacity (MBC) and thyroxine- and T3-stimulated cellular oxygen consumption and glucose consumption were examined in mononuclear blood cells from six patients with liver cirrhosis (LC), in six patients with alcoholic hepatitis (AH), and in six healthy control subjects.
Serum T3 was decreased in patients with LC. The MBC of T3 was increased significantly (P < 0·05) in cells from patients with LC compared with patients with AH and controls, whereas the equilibrium association constants did not differ. Unstimulated glucose consumption was slightly increased (P < 0·05) in cells from patients with AH and LC compared with controls. Thyroid hormone-stimulated glucose consumption was significantly (P < 0·05) increased in cells from patients with LC compared with controls and patients with AH.
Unstimulated oxygen consumption did not differ between the groups, but thyroid hormone-stimulated oxygen consumption was depressed in cells from patients with AC (P < 0·05) compared with patients with LC and with controls.
We conclude that both thyroid hormone-stimulated glucose consumption and T3 nuclear receptor binding in cells from patients with LC are increased, and suggest that the observed changes are responsible for maintenance of euthyroidism in the face of reduced circulating T3.
Journal of Endocrinology (1991) 128, 321–325
